Research and Development

AstraZeneca has signed an agreement giving it worldwide exclusive rights to California-based Ardelyx’s NHE3 inhibitor programme targeting liver and kidney …

Novasep has announced the appointment of Roger-Marc Nicoud, founder and chief executive, as non-executive chairman of the Board. The manufacturing …

The received wisdom today among the ‘digirati’ is that the pharmaceutical industry must join in the online conversation, and to …

Detailed data from the Phase III trial of Sanofi’s newly-licenced anti-VEGF cancer drug Zaltrap, co-marketed with Regeneron, has been published. …

Contract research organisation Chiltern International has announced a successor to chief executive Glenn Kerkhof, who is stepping down to be …

The BioIndustry Association (BIA) has appointed Harren Jhoti and Will West to its Board of directors at its Annual General …

GW Pharmaceuticals has announced the appointment of Christopher John Tovey to the newly created position of chief operating officer. Tovey, …

Christine Beasley and Sarah Harkness have been confirmed as non-executive directors of the NHS Trust Development Authority.  Ms Beasley (pictured) …

Bayer HealthCare and Evotec have signed a five-year deal to look for three novel drugs to treat women with endometriosis. …

The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …

Somerset, NJ, September 13, 2012 – Catalent Pharma Solutions and CTC Bio have entered into a collaboration to provide optimal …

GlaxoSmithKline’s renal cell carcinoma drug Votrient has proved itself non-inferior to a bitter rival, Pfizer’s Sutent, in terms of progression-free …

HORSHAM, UK — September 13, 2012 – Cmed Clinical Services has today announced three new appointments to its management team …

Bristol-Myers Squibb’s melanoma drug Yervoy helps patients survive for longer than if they are receiving standard chemotherapy alone, according to …

Sanofi has appointed Dr Paul Chew as chief medical officer and head of global medical affairs. Taking up his post …